OGIVRI

This brand name is authorized in Austria, Australia, Canada, Estonia, Spain, France, Croatia, Ireland, Israel, Italy, Lithuania, Netherlands, New Zealand, Poland, Romania, Singapore, United States, South Africa

Active ingredients

The drug OGIVRI contains one active pharmaceutical ingredient (API):

1 Trastuzumab UNII P188ANX8CK - TRASTUZUMAB

Trastuzumab is a recombinant humanised IgG1 monoclonal antibody against the human epidermal growth factor receptor 2 (HER2). Τrastuzumab has been shown, in both in vitro assays and in animals, to inhibit the proliferation of human tumour cells that overexpress HER2. Read about Trastuzumab

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC code	Group title	Classification
L01FD01	Trastuzumab	L Antineoplastic and immunomodulating agents → L01 Antineoplastic agents → L01F Monoclonal antibodies and antibody drug conjugates → L01FD HER2 (Human Epidermal Growth Factor Receptor 2) inhibitors
Discover more medicines within L01FD01

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
Country: AU	Pharmaceutical Benefits Scheme	Identifier(s): 10383L, 10391X, 10401K, 10402L, 10581X, 10588G, 10589H, 10597R, 4632T, 4639E, 4650R, 4703M, 7264H, 7265J, 7266K, 7267L
Country: CA	Health Products and Food Branch	Identifier(s): 02474425, 02474433
Country: EE	Ravimiamet	Identifier(s): 1784998, 1824724
Country: ES	Centro de información online de medicamentos de la AEMPS	Identifier(s): 1181341001, 1181341002
Country: FR	Base de données publique des médicaments	Identifier(s): 60990496, 65643371
Country: IL	מִשְׂרַד הַבְּרִיאוּת	Identifier(s): 8479
Country: IT	Agenzia del Farmaco	Identifier(s): 047477017, 047477029
Country: LT	Valstybinė vaistų kontrolės tarnyba	Identifier(s): 1086874, 1088329
Country: NL	Z-Index G-Standaard, PRK	Identifier(s): 150975, 57991
Country: NZ	Medicines and Medical Devices Safety Authority	Identifier(s): 20299, 20300
Country: PL	Rejestru Produktów Leczniczych	Identifier(s): 100323378, 100416832
Country: RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	Identifier(s): W68011001
Country: SG	Health Sciences Authority	Identifier(s): 15850P
Country: US	FDA, National Drug Code	Identifier(s): 67457-991
Country: ZA	Health Products Regulatory Authority	Identifier(s): 52/26/0215.213, 52/26/0216.214